Yvonne Herrmann

Biofunctionalized Silica Nanoparticles: Standards in Amyloid-β Oligomer-Based Diagnosis of Alzheimer’s Disease

Maren Hülsemann, Christian Zafiu, Katja Kühbach et al. · Journal of Alzheimer s Disease · 2016 · 39 citations

Nanoparticle standards for immuno-based quantitation of α-synuclein oligomers in diagnostics of Parkinson's disease and other synucleinopathies

Yvonne Herrmann, Tuyen Bujnicki, Christian Zafiu et al. · Clinica Chimica Acta · 2017 · 29 citations

Nanoparticles, Neurodegenerative Diseases, Engineering +12

Application of an Amyloid Beta Oligomer Standard in the sFIDA Assay

Katja Kühbach, Maren Hülsemann, Yvonne Herrmann et al. · Frontiers in Neuroscience · 2016 · 28 citations · Full text

Engineering, Neurophysiological Biomarkers, Neurochemical Biomarkers +18

sFIDA automation yields sub-femtomolar limit of detection for Aβ aggregates in body fluids

Yvonne Herrmann, Andreas Kulawik, Katja Kühbach et al. · Clinical Biochemistry · 2016 · 21 citations

Engineering, Body Fluids, Medicine +7

Analysis of anticoagulants for blood-based quantitation of amyloid β oligomers in the sFIDA assay

Kateryna Kravchenko, Andreas Kulawik, Maren Hülsemann et al. · Biological Chemistry · 2016 · 18 citations